Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
State Policy: Virginia Delegate Files Ban on Prescription Commercial Data
Virginia Assembly Delegate, Mark D. Sickles (Dem., Springfield), a proponent of bringing investment in Bio Tech and Biosciences…
Eli Lilly: Settles for 1.4 Billion, Now the Details
Eli Lilly agreed to pay $1.4 Billion to the U.S. government to settle criminal and civil cases surrounding the promotion of…
IOM: ACCME Testimony – IOM – Try Again
The ACCME does believe that an enhanced research enterprise can help ACCME meet its mission – but we are not sure that any…
State Policy: Texas introduces Two Transparency Bills “Everybody Loves…
”Everybody loves Transparency - this was the theme of a recent Dallas Morning News article outlining two transparency bills SB…
Grassley: GSK Avandia Email Report — Looking Over Your Shoulder
According to The Wall Street Journal, coming soon to your local newspaper is a report from Senator Grassley on e-mails his staff…
FDA: Issues Guidance on Journal Reprints
In a move that has many wondering where it came from (as it was not on the Bush list of priorities prior to leaving office),…
Health Care Reform: Kennedy Legacy to Speed Process
Senator Edward Kennedy’s health has transformed President-elect Barack Obama’s plan to reform national healthcare into a legacy…
FDA: Vytorin Scare a False Alarm
After a one-year safety review of Vytorin, the FDA announced that patients should stay on Vytorin therapy.
According to the FDA…
Massachusetts Physician Registry: MWE Unraveling the Web of Confusion
When you read the proposed regulations from Massachusetts, you get a headache trying to figure out how they will deal with the…